X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (21) 21
rats (20) 20
rats, sprague-dawley (18) 18
male (16) 16
microdialysis (16) 16
dopamine (12) 12
cocaine (11) 11
dopamine - metabolism (10) 10
neurosciences (9) 9
nucleus accumbens - metabolism (9) 9
pharmacology & pharmacy (9) 9
addiction (8) 8
conditioned place preference (8) 8
ventral tegmental area (8) 8
vigabatrin (8) 8
cocaine - pharmacology (7) 7
dopamine uptake inhibitors - pharmacology (7) 7
extracellular dopamine (7) 7
nucleus accumbens - drug effects (7) 7
substance abuse (7) 7
inhalants (6) 6
brain (5) 5
gaba (5) 5
nucleus-accumbens dopamine (5) 5
organic-solvents (5) 5
pet (5) 5
positron emission tomography (5) 5
4-aminobutyrate transaminase - antagonists & inhibitors (4) 4
administration, inhalation (4) 4
drug synergism (4) 4
freely moving rats (4) 4
gamma-aminobutyric acid - analogs & derivatives (4) 4
locomotor-activity (4) 4
mice (4) 4
nucleus-accumbens (4) 4
pharmacokinetics (4) 4
psychiatry (4) 4
vigabatrin - pharmacology (4) 4
anticonvulsants - pharmacology (3) 3
brain - diagnostic imaging (3) 3
brain - metabolism (3) 3
chemistry, medicinal (3) 3
dose-response relationship, drug (3) 3
enzyme inhibitors - pharmacology (3) 3
exposure (3) 3
extracellular space - metabolism (3) 3
female (3) 3
gamma vinyl-gaba (3) 3
gamma-aminobutyric acid - pharmacology (3) 3
heroin (3) 3
humans (3) 3
injections, intraperitoneal (3) 3
medial prefrontal cortex (3) 3
methylphenidate - pharmacology (3) 3
motor activity - drug effects (3) 3
nicotine (3) 3
nucleus accumbens (3) 3
papio (3) 3
prefrontal cortex - metabolism (3) 3
radiology, nuclear medicine & medical imaging (3) 3
rat (3) 3
stereoisomerism (3) 3
time factors (3) 3
tissue distribution (3) 3
treatment (3) 3
vinyl-gaba (3) 3
4-aminobutyrate transaminase - metabolism (2) 2
behavior (2) 2
brain uptake (2) 2
c-11 raclopride (2) 2
carbon radioisotopes - pharmacokinetics (2) 2
carrier proteins - antagonists & inhibitors (2) 2
cocaine - antagonists & inhibitors (2) 2
conditioning (2) 2
conditioning, operant - drug effects (2) 2
deficit hyperactivity disorder (2) 2
dopamine - secretion (2) 2
dopamine plasma membrane transport proteins (2) 2
drug administration schedule (2) 2
dual-probe microdialysis (2) 2
ethanol (2) 2
extracellular space - drug effects (2) 2
gaba antagonists - pharmacology (2) 2
gamma vinyl gaba (2) 2
gamma vinyl‐gaba (2) 2
gamma-aminobutyric acid - metabolism (2) 2
gamma-vinyl gaba (2) 2
heroin - pharmacology (2) 2
in-vivo microdialysis (2) 2
index medicus (2) 2
induced dopamine release (2) 2
induced increases (2) 2
injections, subcutaneous (2) 2
isotope labeling - methods (2) 2
locus-coeruleus (2) 2
membrane glycoproteins (2) 2
membrane transport proteins (2) 2
methyl-d-aspartate (2) 2
methylphenidate (2) 2
mitochondria - genetics (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Synapse, ISSN 0887-4476, 10/1999, Volume 34, Issue 1, pp. 11 - 19
We examined the acute effect of the irreversible GABA‐transaminase inhibitor, gamma‐vinyl GABA (GVG, Sabril®, Vigabatrin®) on increases in nucleus accumbens... 
heroin | Vigabatrin | microdialysis | methamphetamine | Sabril | addiction | gamma vinyl‐GABA | positron emission tomography | ethanol | dopamine | Dopamine | Microdialysis | Addiction | Ethanol | Gamma vinyl- GABA | Methamphetamine | Positron emission tomography | Heroin | FREELY MOVING RATS | IN-VIVO MICRODIALYSIS | EXTRACELLULAR DOPAMINE | gamma vinyl-GABA | CONDITIONED PLACE PREFERENCE | RELEASE | SUBSTANTIA-NIGRA | NEUROSCIENCES | VENTRAL TEGMENTAL AREA | C-11 RACLOPRIDE | OPIOID RECEPTORS | Analgesics, Opioid - antagonists & inhibitors | Dopamine Uptake Inhibitors - antagonists & inhibitors | Nucleus Accumbens - metabolism | Analgesics, Opioid - pharmacology | Male | Anticonvulsants - pharmacology | Central Nervous System Depressants - pharmacology | Dopamine - cerebrospinal fluid | Methamphetamine - antagonists & inhibitors | Extracellular Space - metabolism | Time Factors | Dopamine - metabolism | Heroin - pharmacology | Methamphetamine - pharmacology | Dopamine Uptake Inhibitors - pharmacology | Central Nervous System Depressants - antagonists & inhibitors | Rats | gamma-Aminobutyric Acid - pharmacology | Rats, Sprague-Dawley | Heroin - antagonists & inhibitors | Ethanol - pharmacology | Animals | Nucleus Accumbens - drug effects | gamma-Aminobutyric Acid - analogs & derivatives | Ethanol - antagonists & inhibitors
Journal Article
Journal of Medicinal Chemistry, ISSN 0022-2623, 01/2012, Volume 55, Issue 1, pp. 357 - 366
Journal Article
Journal Article
Journal of Medicinal Chemistry, ISSN 0022-2623, 1/2012, Volume 55, Issue 1, pp. 357 - 366
Vigabatrin, a GABA aminotransferase (GABA-AT) inactivator, is used to treat infantile spasms and refractory complex partial seizures and is in clinical trials... 
Addiction | Conditioned place preference | GABA aminotransferase | Enzyme inactivator | Visual field defect | Micro-PET imaging | Cocaine | Pharmacokinetics
Journal Article
Neuropsychopharmacology, ISSN 0893-133X, 2002, Volume 27, Issue 2, pp. 163 - 170
Although stress is an extensively investigated phenomenon, the effects of specific stressors on the pharmacologic activity of routinely administered drugs are... 
Medial prefrontal cortex | Norepinephrine | Dopamine | Microdialysis | Methylphenidate | Handling stress | norepinephrine | methylphenidate | EXTRACELLULAR DOPAMINE | medial prefrontal cortex | NORADRENALINE RELEASE | DOPAMINE RELEASE | PSYCHIATRY | LOCOMOTOR-ACTIVITY | NEUROSCIENCES | DUAL-PROBE MICRODIALYSIS | VENTRAL TEGMENTAL AREA | NUCLEUS-ACCUMBENS | INDUCED INCREASE | microdialysis | LOCUS-COERULEUS | handling stress | PHARMACOLOGY & PHARMACY | RAT-BRAIN | dopamine | Motor Activity - physiology | Neural Pathways - drug effects | Synaptic Transmission - physiology | Catecholamines - metabolism | Catecholamines - secretion | Prefrontal Cortex - physiopathology | Extracellular Space - drug effects | Motor Activity - drug effects | Male | Extracellular Space - metabolism | Dopamine - secretion | Prefrontal Cortex - drug effects | Stress, Physiological - metabolism | Synaptic Transmission - drug effects | Norepinephrine - secretion | Handling (Psychology) | Neural Pathways - physiopathology | Dopamine - metabolism | Acute Disease | Ventral Tegmental Area - drug effects | Drug Administration Schedule | Presynaptic Terminals - drug effects | Ventral Tegmental Area - physiopathology | Rats | Methylphenidate - pharmacology | Stress, Physiological - physiopathology | Rats, Sprague-Dawley | Animals | Norepinephrine - metabolism | Ventral Tegmental Area - metabolism | Prefrontal Cortex - metabolism | Neural Pathways - metabolism | Presynaptic Terminals - metabolism | Adrenergic Uptake Inhibitors - pharmacology
Journal Article
Journal of Labelled Compounds and Radiopharmaceuticals, ISSN 0362-4803, 03/2002, Volume 45, Issue 3, pp. 199 - 211
γ‐Vinyl‐γ‐aminobutyric acid (GVG, Vigabatrin®), a suicide inhibitor of GABA‐transaminase (GABA‐T), has been suggested as a new drug for the treatment of... 
GVG | GABA‐T | Vigabatrin | vinyl‐GABA | C‐11 positron emission tomography (PET) | GABA-T | C-11 positron emission tomography (PET) | Vinyl-GABA
Journal Article
Journal Article
Journal of Labelled Compounds and Radiopharmaceuticals, ISSN 0362-4803, 03/2002, Volume 45, Issue 3, p. 199
Journal Article
Journal Article